Zeureka wrote:Sorry, checked my statement above a bit: Zambonis "CCSVI in patients with MS"paper reveals he checked 65 with MS:
- 35 RR (with EDSS 0.5-2, with average 1.5) - disease duration average 6 years
- 20 secondary progressive (EDSS 3.5-6.5, average 5) - dda 13 years
- 10 primary progressive (EDSS average 3-6.5, average 4.3) - dda 10 years
Thanks for checking...I should read through the original research again too. But if he was finding azygous lesions even on the RRs and Dake and Buffalo weren't, then either there's a difference in their abilites to find the stenosis or their definition of whether something is a stenosis or not, or there's a legitimate difference in the frequency of azygous stenoses in Italians vs. Americans. And if there is a legitimate difference, are Americans doing something in particular that increases the likelihood of upper internal jugular stenosis and/or are Italians doing something in particular that increases the likelihood of azygous stenosis? Or are Italians in some way genetically inclined not to get the upper internal jugular stenoses, etc.? Seriously, CCSVI raises so many questions, it's a sandbox for researchers right now. Most likely there's a difference in methods between Dake and Buffalo vs Zamboni, don't you think, that's causing the differences in location of stenoses? Not a difference between Italians vs Americans? For the joint endovascular treatment results, did each side do diagnoses on the same patients, so that they come with up consensus, or did Zamboni do the Italians and Buffalo the Americans? Depending on how it was conducted, it could shed some light on this.
"However, the truth in science ultimately emerges, although sometimes it takes a very long time," Arthur Silverstein, Autoimmunity: A History of the Early Struggle for Recognition